Literature DB >> 34482508

Assessing the prevalence and predicting factors of an abnormal gated myocardial perfusion SPECT in asymptomatic patients with type 2 diabetes.

E Hosseinzadeh1,2, Mohammadali Ghodsirad3,4,5, T Alirezaie1,6, M Arfenia1,2, M Amoui1,2, E Pirayesh1,2, G Norouzi1,2, S Khoshbakht1,2.   

Abstract

Considering the significant prevalence of silent myocardial ischemia and its related morbidity and mortality in asymptomatic type 2 diabetic patients, it is not well known whether early screening with MPI is cost-effective and predicting factors are not well elucidated. This was a cross-sectional study including 63 asymptomatic patients with type 2 diabetes mellitus (T2DM), with normal ECG and ejection fraction. Patients with any history of documented valvular, congestive or ischemic heart disease, renal or hepatic failure were excluded. At first all patients were interviewed and checked for risk factors and then patients underwent a two-day rest/stress 99mTc-MIBI gated MPI SPECT. Data was assessed by QPS/QGS and 4DM software and evaluated by a nuclear medicine specialist with summed stress score (SSS) of more than 4 defined as CAD. There were 42 females (67%) and 21 males (33%), with a mean age of 61.33 ± 6.98 years and 7.97 ± 4.86 years history of T2DM. CAD was detected in 26 (41.3%) patients and was significantly associated with male gender, smoking and requiring insulin therapy (P-value = 0.019, 0.046, 0.05, respectively). A significant association was found between the duration of diabetes, especially when > 15 years, and the probability of having CAD. Multivariable logistic regression revealed that smoking; male gender and diabetes duration were the strongest independent predictors of abnormal MPI results. We found a high (46%) prevalence of abnormal stress MPI SPECT in patients with type 2 diabetes mellitus, despite being asymptomatic. Asymptomatic patients with a history of smoking, long duration of diabetes, being under insulin treatment and male gender might benefit from MPI for early detection of silent ischemia.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  99mTc-MIBI; Asymptomatic CAD; Early screening; Gated myocardial perfusion imaging; Silent ischemia; Type 2 diabetes mellitus

Mesh:

Year:  2021        PMID: 34482508     DOI: 10.1007/s10554-021-02400-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  6 in total

1.  Increased right ventricular uptake on stress SPECT myocardial perfusion images in a patient with severe coronary artery disease.

Authors:  John P Higgins
Journal:  J Nucl Cardiol       Date:  2006-09       Impact factor: 5.952

2.  Prognostic value of coronary flow reserve in patients with suspected or known coronary artery disease referred to PET myocardial perfusion imaging: A meta-analysis.

Authors:  Roberta Green; Valeria Cantoni; Wanda Acampa; Roberta Assante; Emilia Zampella; Carmela Nappi; Valeria Gaudieri; Teresa Mannarino; Renato Cuocolo; Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2019-12-24       Impact factor: 5.952

3.  The prognostic value of myocardial perfusion imaging in patients with type 2 myocardial infarction.

Authors:  Chad M Colon; Ramey L Marshell; Christopher P Roth; Ayman A Farag; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2019-10-23       Impact factor: 5.952

4.  Transient ischemic dilation or transient RV visualization in patients with normal SPECT stress myocardial perfusion imaging: Correlation with CT coronary artery calcium scoring and coronary angiography.

Authors:  Behshad Naghshtabrizi; Maryam Alvandi; Zahra Shaghaghi; Seyed Kamaledin Hadei; Farnaz Fariba; Mehdi Moradi; Mohammad Ali Seif Rabie
Journal:  J Nucl Cardiol       Date:  2021-07-06       Impact factor: 3.872

5.  Diagnostic and prognostic significance of transient ischemic dilation (TID) in myocardial perfusion imaging: A systematic review and meta-analysis.

Authors:  Mohamed Alama; Christopher Labos; Handel Emery; Robert M Iwanochko; Michael Freeman; Mansoor Husain; Douglas S Lee
Journal:  J Nucl Cardiol       Date:  2017-09-25       Impact factor: 5.952

Review 6.  Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros.

Authors:  Konstantinos Makrilakis; Stavros Liatis
Journal:  J Diabetes Res       Date:  2017-12-14       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.